Large-cap Health Care company Pfizer has logged a -1.1% change today on a trading volume of 14,783,524. The average volume for the stock is 24,536,955.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Based in New York, United States the company has 83,000 full time employees and a market cap of $189,704,257,536. Pfizer currently offers its equity investors a dividend that yields 4.8% per year.
The company is now trading -24.29% away from its average analyst target price of $44.38 per share. The 21 analysts following the stock have set target prices ranging from $32.0 to $75.0, and on average give Pfizer a rating of buy.
Over the last 12 months PFE shares have declined by -22.0%, which represents a difference of -40.0% when compared to the S&P 500. The stock's 52 week high is $54.93 per share and its 52 week low is $33.44. With its net margins declining an average -4.4% over the last 6 years, Pfizer declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 100,330,000 | 31,370,000 | 31 | 14.81 |
| 2022-02-24 | 81,288,000 | 21,980,000 | 27 | 22.73 |
| 2021-02-25 | 41,651,000 | 9,160,000 | 22 | -43.59 |
| 2020-02-27 | 40,905,000 | 16,026,000 | 39 | 44.44 |
| 2019-02-28 | 40,825,000 | 11,153,000 | 27 | -34.15 |
| 2018-02-22 | 52,546,000 | 21,309,000 | 41 |
